UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 223

Sortiert nach

Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study

American journal of transplantation, 2009-05, Vol.9 (5), p.1081-1086

2009

Volltextzugriff (PDF)

Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure

Bone marrow transplantation (Basingstoke), 2007-08, Vol.40 (3), p.225-233

2007

Volltextzugriff (PDF)

LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

Science (American Association for the Advancement of Science), 2003-10, Vol.302 (5644), p.415-419

2003

Volltextzugriff (PDF)

Gene Therapy for Primary Immunodeficiencies

Hematology/oncology clinics of North America, 2011-02, Vol.25 (1), p.89-100

2011

Volltextzugriff (PDF)

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

Leukemia, 2011-09, Vol.25 (9), p.1471-1483

2011

Volltextzugriff (PDF)

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Bone marrow transplantation (Basingstoke), 2006-03, Vol.37 (5), p.439-449

2006

Volltextzugriff (PDF)

Basic research tries to decrease the risks of translational medicine

Gene therapy, 2009-03, Vol.16 (3), p.309-310

Cavazzana-Calvo, M

2009

Volltextzugriff (PDF)

Gene therapy for severe combined immunodeficiency: are we there yet?

The Journal of clinical investigation, 2007-06, Vol.117 (6), p.1456-1465

2007

Volltextzugriff (PDF)

thérapie génique des déficits immunitaires

Journal de pédiatrie et de puériculture, 2002, Vol.15 (1), p.4-10

2002

Volltextzugriff (PDF)

LentiGlobin gene therapy for transfusion-dependent β-Thalassemia: Update from the northstar HGB-204 phase 1/2 clinical study

Cytotherapy (Oxford, England), 2017-05, Vol.19 (5), p.S19-S19

2017

Volltextzugriff (PDF)

NATURALLY OCCURRING PRIMARY DEFICIENCIES OF THE IMMUNE SYSTEM

Annual review of immunology, 1997-01, Vol.15 (1), p.93-124

1997

Volltextzugriff (PDF)

Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002

Blood, 2004-02, Vol.103 (3), p.1152-1157

2004

Volltextzugriff (PDF)

Moelle osseuse: réservoir de cellules souches réparatrices de différents tissus ?

Annales de biologie clinique (Paris), 2004-03, Vol.62 (2), p.131-138

2004

Volltextzugriff (PDF)

Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation

Cytotherapy (Oxford, England), 2005-05, Vol.7 (2), p.102-108

2005

Volltextzugriff (PDF)

Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency : A European retrospective study of 116 patients

Blood, 1998-05, Vol.91 (10), p.3646-3653

1998

Volltextzugriff (PDF)

Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency

Gene therapy, 2012-08, Vol.19 (8), p.872-876

2012

Volltextzugriff (PDF)

The future of gene therapy

Nature, 2004-02, Vol.427 (6977), p.779-781

2004

Volltextzugriff (PDF)

Fragile sites are preferential targets for integrations of MLV vectors in gene therapy

Gene therapy, 2006-07, Vol.13 (13), p.1057-1059

2006

Volltextzugriff (PDF)

Transient familial haemophagocytic lymphohistiocytosis reactivation post‐CD34 haematopoietic stem cell transplantation

British journal of haematology, 2005-08, Vol.130 (3), p.404-408

2005

Volltextzugriff (PDF)

A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency

The New England journal of medicine, 2003-01, Vol.348 (3), p.255-256

2003

Volltextzugriff (PDF)

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de Moelle (SFGM)

British journal of haematology, 2000-02, Vol.108 (2), p.400-407

2000

Volltextzugriff (PDF)

Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

The Lancet (British edition), 2003-02, Vol.361 (9357), p.553-560

2003

Volltextzugriff (PDF)

Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy

The New England journal of medicine, 2002-04, Vol.346 (16), p.1185-1193

2002

Volltextzugriff (PDF)

Severe combined immunodeficiency. A model disease for molecular immunology and therapy

Immunological reviews, 2005-02, Vol.203 (1), p.98-109

2005

Volltextzugriff (PDF)

Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency

Cell, 2001-04, Vol.105 (2), p.177-186

2001

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(200)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(126)
Science & Technology
(122)
Life Sciences & Biomedicine
(118)
Biological And Medical Sciences
(69)
Medical Sciences
(68)
Hematology
(51)
Male
(45)
Severe Combined Immunodeficiency - Therapy
(45)
Immunology
(41)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(37)
Female
(37)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(36)
Animals
(34)
Severe Combined Immunodeficiency - Genetics
(34)
Infant
(33)
Child
(28)
Gene Therapy
(28)
Hematopoietic Stem Cell Transplantation
(28)
Child, Preschool
(27)
Genetic Therapy
(26)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study

Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure

LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

Gene Therapy for Primary Immunodeficiencies

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Basic research tries to decrease the risks of translational medicine

Gene therapy for severe combined immunodeficiency: are we there yet?

thérapie génique des déficits immunitaires

LentiGlobin gene therapy for transfusion-dependent β-Thalassemia: Update from the northstar HGB-204 phase 1/2 clinical study

NATURALLY OCCURRING PRIMARY DEFICIENCIES OF THE IMMUNE SYSTEM

Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002

Moelle osseuse: réservoir de cellules souches réparatrices de différents tissus ?

Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation

Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency : A European retrospective study of 116 patients

Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency

The future of gene therapy

Fragile sites are preferential targets for integrations of MLV vectors in gene therapy

Transient familial haemophagocytic lymphohistiocytosis reactivation post‐CD34 haematopoietic stem cell transplantation

A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de Moelle (SFGM)

Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy

Severe combined immunodeficiency. A model disease for molecular immunology and therapy

Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency

Suchergebnisse filtern